Quercetin 3-O-neohesperidoside
CAS No. 32453-36-4
Quercetin 3-O-neohesperidoside( —— )
Catalog No. M31947 CAS No. 32453-36-4
Quercetin 3-O-neohesperidoside shows anti-atherosclerosis, and antiplatelet aggregation activities.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 144 | In Stock |
|
| 10MG | 235 | In Stock |
|
| 25MG | 397 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameQuercetin 3-O-neohesperidoside
-
NoteResearch use only, not for human use.
-
Brief DescriptionQuercetin 3-O-neohesperidoside shows anti-atherosclerosis, and antiplatelet aggregation activities.
-
DescriptionQuercetin 3-O-neohesperidoside shows anti-atherosclerosis, and antiplatelet aggregation activities.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number32453-36-4
-
Formula Weight610.5
-
Molecular FormulaC27H30O16
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
PACAP-38 (28-38) (hu...
PACAP-38 (28-38) (human, chicken, mouse, ovine, porcine, rat) is a polypeptide that can be found by peptide screening. Peptide screening is a research tool that pools active peptides primarily by immunoassay. Peptide screening can be used for protein interaction, functional analysis, epitope screening, especially in the field of agent research and development.
-
Parimifasor
Parimifasor(LYC-30937-EC, LYC30937) is an orally bioavailable, enteric-coated ATPase modulator as a gut-directed therapy for the treatment of inflammatory bowel disease (IBD).
-
A2ti-2
A2ti-2 is a low affinity and selective inhibitor of the membrane-bound protein A2/S100A10 heterotetramer (A2t) (IC50 : 230 μM).
Cart
sales@molnova.com